Ratio Therapeutics, Macrocyclics Partner for Chelator Distribution
June 13, 2025
Ratio Therapeutics Inc., a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, announced that it entered into an agreement granting